Drug delivery system targets liver cancer

May 2008
Hospice Management Advisor;May2008, Vol. 13 Issue 5, p57
The article focuses on the drug delivery system that targets liver cancer, developed by Delcath Systems Inc. in New York City. The company has reached Phase III trials with the technology that facilitates high dose delivery of chemotherapy directly to the liver to treat liver cancer. The system uses an invasive procedure and catheter technology to separate blood flow from the liver and allows the extraction of a bolus of chemotherapy to prevent systemic toxicities.


Related Articles

  • Delcath's drug delivery system targeting deadly liver cancer. Yoffee, Lynn // Medical Device Daily;3/3/2008, Vol. 12 Issue 42, p1 

    The article reports on the success of Delcath Systems to reach Phase III trials for a technology that facilitates ultra-high dose delivery of chemotherapy directly to the liver to treat liver cancer. The technology uses a minimally invasive procedure combined with a catheter technology to...

  • FDA ROUNDUP:.  // MondayMorning;2/28/2011, Vol. 18 Issue 8, p14 

    The article presents information on the role of U.S. Food and Drug Administration (FDA) in pharmaceutical industry. FDA has refused to accept the marketing application of Delcath Systems Inc. for its cancer drug delivery system. Whereas FDA accepted a hearing for Genentech Inc. to argue in favor...

  • Delcath receives CE mark for new Chemosat.  // Medical Device Daily;4/11/2012, Vol. 16 Issue 70, p7 

    The article reports on the CE mark approval received by Delcath Systems for the second generation hemofiltration cartridge of the company's Hepatic Chemostat delivery system.

  • Delcath gets CE mark for Hepatic Chemostat.  // Medical Device Daily;4/14/2011, Vol. 15 Issue 72, p6 

    The article reports on the Conformite Europeene (CE) mark approval granted to Delcath Systems of New York for its Hepatic Chemostat delivery system, with an indication for the percutaneous intra-arterial administration of a chemotherapeutic agent, melphalan hydrochloride, to the liver.

  • Cancer: One step at a time. Mooney, David // Nature;7/28/2005, Vol. 436 Issue 7050, p468 

    Discusses the innovative approach to killing tumor cells using traditional chemotherapy. Side effects of chemotherapy; Benefits of the simultaneous delivery of chemotherapeutic and anti-angiogenic drugs; Reduction of blood flow from potential resistance to drug therapy and tumor invasiveness.

  • Saccharide Modified Pharmaceutical Nanocarriers for Targeted Drug and Gene Delivery. Wangyang Yu; Na Zhang; Changjun Li // Current Pharmaceutical Design;11/11/2009, Vol. 15 Issue 32, p3826 

    Nanocarriers are effective non-viral vectors for drug and gene delivery with low immunogenicity in comparison with viral vectors. However, the lack of organ or cell specificity sometimes hinders their application and brings about unexpected side effects. Active targeting is an outstanding...

  • PHARMACOSOMES: AN EMERGING VESICULAR SYSTEM. Kavitha, D.; Sowjanya, J. Naga; Panaganti, Shanker // International Journal of Pharmaceutical Sciences Review & Resear;Nov2010, Vol. 5 Issue 3, p168 

    Various types of lipid based vesicular systems have been developed in controlled and targeted drug delivery. Pharmacosomes bearing unique advantages over liposomes and niosomes have come up as potential alternative to conventional vesicles. These are the amphiphilic phospholipid complexes of...

  • Recent in Transdermal Drug Delivery systems. Gandhi, Kamal; Dahiya, Anu; Kalra, Taruna; Ashish // Journal of Pharmacy Research;2012, Vol. 5 Issue 8, p4329 

    Transdermal drug delivery system (TDDS) provides a means to sustain drug release as well as reduce the intensity of action and thus reduce the side effects associated with its oral therapy. Transdermal drugs are self-contained, discrete dosage form. It delivers a drug through intact skin at a...

  • New Approach In Targeted Drug Delivery System. Patel, Ronak A.; Modasiya, M.Moin K.; Leuva, Vinayak R.; Patel, Vidhiben R.; Gadhawala, Zakir. M. // Journal of Pharmacy Research;2012, Vol. 5 Issue 8, p4404 

    Targeted drug delivery, sometimes called smart drug delivery, is a method of delivering medication to a patient in a manner that increases the concentration of the medication in a some parts of the body relative to others. The goal of a targeted drug delivery system to prolong, localize, target,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics